The Experts below are selected from a list of 8826 Experts worldwide ranked by ideXlab platform
Klaus Strebhardt - One of the best experts on this subject based on the ideXlab platform.
-
stamping out raf and mek1 2 to inhibit the erk1 2 pathway an Emerging Threat to anticancer therapy
Oncogene, 2016Co-Authors: Ranadip Mandal, Sven Becker, Klaus StrebhardtAbstract:Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an Emerging Threat to anticancer therapy
-
Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an Emerging Threat to anticancer therapy.
Oncogene, 2015Co-Authors: Ranadip Mandal, Sven Becker, Klaus StrebhardtAbstract:Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an Emerging Threat to anticancer therapy
Nicola Zetola - One of the best experts on this subject based on the ideXlab platform.
-
Nosocomial transmission of community-associated meticillin-resistant Staphylococcus aureus: an Emerging Threat
2020Co-Authors: Nicola ZetolaAbstract:1have described the Emerging Threat of meticillin-resistant Staphylococcus aureus (MRSA) infection acquired in the community by patients without previous health-care contact. Compared with health-care-associated MRSA, community-associated strains are typically susceptible to most antistaphylococcal antimicrobials, have a more diverse genetic background, carry small versions (usually types IV or V) of staphylococcal cassette chromosome mec (SCCmec), often produce the Panton-Valentine leukocidin (PVL), and can be highly
-
community acquired meticillin resistant staphylococcus aureus an Emerging Threat
Lancet Infectious Diseases, 2005Co-Authors: Nicola Zetola, John S Francis, Eric L Nuermberger, William R BishaiAbstract:Summary Community-acquired meticillin-resistant Staphylococcus aureus (MRSA) is becoming an important public-health problem. New strains of S aureus displaying unique combinations of virulence factors and resistance traits have been associated with high morbidity and mortality in the community. Outbreaks of epidemic furunculosis and cases of severe invasive pulmonary infections in young, otherwise healthy people have been particularly noteworthy. We review the characteristics of these new strains of community-acquired MRSA that have contributed to their pathogenicity and discuss new approaches to the diagnosis and management of suspected and confirmed community-acquired MRSA infections.
William R Bishai - One of the best experts on this subject based on the ideXlab platform.
-
community acquired meticillin resistant staphylococcus aureus an Emerging Threat
Lancet Infectious Diseases, 2005Co-Authors: Nicola Zetola, John S Francis, Eric L Nuermberger, William R BishaiAbstract:Summary Community-acquired meticillin-resistant Staphylococcus aureus (MRSA) is becoming an important public-health problem. New strains of S aureus displaying unique combinations of virulence factors and resistance traits have been associated with high morbidity and mortality in the community. Outbreaks of epidemic furunculosis and cases of severe invasive pulmonary infections in young, otherwise healthy people have been particularly noteworthy. We review the characteristics of these new strains of community-acquired MRSA that have contributed to their pathogenicity and discuss new approaches to the diagnosis and management of suspected and confirmed community-acquired MRSA infections.
Ranadip Mandal - One of the best experts on this subject based on the ideXlab platform.
-
stamping out raf and mek1 2 to inhibit the erk1 2 pathway an Emerging Threat to anticancer therapy
Oncogene, 2016Co-Authors: Ranadip Mandal, Sven Becker, Klaus StrebhardtAbstract:Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an Emerging Threat to anticancer therapy
-
Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an Emerging Threat to anticancer therapy.
Oncogene, 2015Co-Authors: Ranadip Mandal, Sven Becker, Klaus StrebhardtAbstract:Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an Emerging Threat to anticancer therapy
Anne E Ballmann - One of the best experts on this subject based on the ideXlab platform.
-
snake fungal disease an Emerging Threat to wild snakes
Philosophical Transactions of the Royal Society B, 2016Co-Authors: Jeffrey M Lorch, Susan Knowles, Julia S Lankton, Kathy Michell, Jaime L Edwards, Joshua M Kapfer, Richard A Staffen, Erik R Wild, Katie Z Schmidt, Anne E BallmannAbstract:Since 2006, there has been a marked increase in the number of reports of severe and often fatal fungal skin infections in wild snakes in the eastern USA. The Emerging condition, referred to as snake fungal disease (SFD), was initially documented in rattlesnakes, where the infections were believed to pose a risk to the viability of affected populations. The disease is caused by Ophidiomyces ophiodiicola , a fungus recently split from a complex of fungi long referred to as the Chrysosporium anamorph of Nannizziopsis vriesii (CANV). Here we review the current state of knowledge about O. ophiodiicola and SFD. In addition, we provide original findings which demonstrate that O. ophiodiicola is widely distributed in eastern North America, has a broad host range, is the predominant cause of fungal skin infections in wild snakes and often causes mild infections in snakes Emerging from hibernation. This new information, together with what is already available in the scientific literature, advances our knowledge of the cause, pathogenesis and ecology of SFD. However, additional research is necessary to elucidate the factors driving the emergence of this disease and develop strategies to mitigate its impacts. This article is part of the themed issue ‘Tackling Emerging fungal Threats to animal health, food security and ecosystem resilience’.